# Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease

> **NCT00683111** · PHASE4 · COMPLETED · sponsor: **Ruttonjee Hospital** · enrollment: 500 (estimated)

## Conditions studied

- Acute Coronary Syndrome
- Acute Myocardial Infarction

## Interventions

- **DRUG:** esomeprazole 20 mg daily
- **DRUG:** famotidine 40 mg daily

## Key facts

- **NCT ID:** NCT00683111
- **Lead sponsor:** Ruttonjee Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2011-12
- **Final completion:** 2011-12
- **Target enrollment:** 500 (ESTIMATED)
- **Last updated:** 2012-06-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00683111

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00683111, "Prevention of Gastrointestinal Bleeding in Patients With Severe Ischemic Heart Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00683111. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*